Overactive Bladder - Results from #420

REVIEW UroToday

Noninvasive spinal neuromodulation mitigates symptoms of idiopathic overactive bladder. April 17, 2022

The Prevalence of Lower Urinary Tract Symptoms and Overactive Bladder in South Korea: A Cross-Sectional, Population-Based Study. April 10, 2022

Efficacy and safety of skin-adhesive low-level light therapy for overactive bladder: a Phase III study. April 10, 2022

Changes in overactive bladder medication following bariatric surgery: segmented regression analysis. April 10, 2022

Why Patients Fall Through the Cracks: Assessment of Patients' Overactive Bladder Treatment. April 3, 2022

Safety and Tolerability of Fesoterodine in Older Adult Patients with Overactive Bladder. April 3, 2022

The Impact of Caffeine Intake on Mental Health Symptoms in Postmenopausal Females with Overactive Bladder Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial. April 3, 2022

Resource use and healthcare costs in patients with overactive bladder who initiate treatment with mirabegron or antimuscarinic monotherapy in Catalonia: the MIRACAT study. March 27, 2022

Mirabegron for overactive bladder in frail patients 80 years or over (HOKUTO study). March 27, 2022

A Community-Based Education Program for Overactive Bladder in a Predominantly Minority Older Female Population: A Pilot Study. March 27, 2022

The emperor has no clothes: OAB can be cured surgically. March 20, 2022

Intravesical botulinum-A toxin in children with refractory non-neurogenic overactive bladder. March 20, 2022

Electronic Health Record-Triggered Research Infrastructure Combining Real-world Electronic Health Record Data and Patient-Reported Outcomes to Detect Benefits, Risks, and Impact of Medication: Development Study. March 20, 2022

What is the real burden of the overactive bladder? Results from a national prevalence study. March 13, 2022

A Physician-Led Communication Initiative to Inform OAB Patients of Dementia Risk Associated With Anticholinergic Medications. March 13, 2022

Urgent PC Versus a Generic Posterior Tibial Neurostimulator for Overactive Bladder: A Retrospective Noninferiority Study. March 13, 2022

An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder. March 13, 2022

Does urinary urgency drive urinary frequency in overactive bladder? March 6, 2022

The gut, vaginal, and urine microbiome in overactive bladder: a systematic review. March 6, 2022

European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1: Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence. February 27, 2022

Page 22 of 121